Saitta, C.; Musso, G.; Garofano, G.; Tanaka, H.; Patil, D.; Meagher, M.F.; Vourganti, S.; Cherullo, E.; Liss, M.; Paciotti, M.;
et al. Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma. Cancers 2025, 17, 3481.
https://doi.org/10.3390/cancers17213481
AMA Style
Saitta C, Musso G, Garofano G, Tanaka H, Patil D, Meagher MF, Vourganti S, Cherullo E, Liss M, Paciotti M,
et al. Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma. Cancers. 2025; 17(21):3481.
https://doi.org/10.3390/cancers17213481
Chicago/Turabian Style
Saitta, Cesare, Giacomo Musso, Giuseppe Garofano, Hajime Tanaka, Dattatraya Patil, Margaret F. Meagher, Srinivas Vourganti, Edward Cherullo, Michael Liss, Marco Paciotti,
and et al. 2025. "Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma" Cancers 17, no. 21: 3481.
https://doi.org/10.3390/cancers17213481
APA Style
Saitta, C., Musso, G., Garofano, G., Tanaka, H., Patil, D., Meagher, M. F., Vourganti, S., Cherullo, E., Liss, M., Paciotti, M., Lughezzani, G., Buffi, N. M., Master, V., Fujii, Y., McKay, R. R., & Derweesh, I. H.
(2025). Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma. Cancers, 17(21), 3481.
https://doi.org/10.3390/cancers17213481
